http://bit.ly/3Ldw0O0 Incredibly excited that Cartesian's Ph2b RCT was positive! Absolutely beautiful data from this first ever RCT of an engineered cell therapy. I'm so grateful to our patients, my Cartesian colleagues, and our investors for your continued support. In 2016, we started the journey with a $600 flow cytometer, a $9 centrifuge (salad spinner), and a big idea that mRNA cell therapy would be potent yet safer than conventional cell therapies. Today - armed with the best team ever, elegant clinical data, some serious capital, an RMAT designation, and a brand new Ph3/commercial facility - we start the sprint to get the first mRNA cell therapy approved for patients with myasthenia and other autoimmune diseases.
Congratulations Murat. It's great to see the continued clinical success.
Congrats to the entire Cartesian team, a very great story in the making. Looking forward to seeing what is next!
Congratulations Murat and everyone at Cartesian! It’s very exciting that I’ve been involved in your journey since 2017 and to see the success you have achieved! Best wishes for continued success!
Murat, congratulations on this milestone.
Murat, congratulations to you and the Cartesian team! Incredible news for patients.
Congrats Murat Kalayoglu to you and your great team!
Great news to read, Murat!
Congratulations! Great read, thanks for sharing!
Chief Executive Officer at Zain Iraq
1moMurat, congratulations! It's always inspiring to hear about the achievements from your and your team's exciting journey..